![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 39, 33453-33460, September 30, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1



****
From the
Department of Biochemistry, University of Cambridge, Cambridge CB2 1GA, United Kingdom, the
Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, United Kingdom, the ¶Synchrotron Radiation Department, CCLRC Daresbury Laboratory, Warrington WA4 AD, United Kingdom, the **Institute of Biotechnology, University of Helsinki, FIN-00014 Helsinki, Finland, and the **Department of Physiology & Biophysics, University of California, Irvine, California 92697
Nerve growth factor (NGF) is the ligand for two unrelated cellular receptors, TrkA and p75NTR, and acts as a mediator in the development and maintenance of the mammalian nervous system. Signaling through TrkA kinase domains promotes neuronal survival, whereas activation of the p75NTR "death domains" induces apoptosis under correct physiological conditions. However, co-expression of these receptors leads to enhanced neuronal survival upon NGF stimulation, possibly through a ternary p75NTR·NGF·TrkA complex. We have expressed human p75NTR ligand binding domain as a secreted glycosylated protein in Trichoplusia ni cells. Following assembly and purification of soluble p75NTR·NGF complexes, mass spectrometry, analytical ultracentrifugation, and solution x-ray scattering measurements are indicative of 2:2 stoichiometry, which implies a symmetric complex. Molecular models of the 2:2 p75NTR·NGF complex based on these data are not consistent with the further assembly of either symmetric (2:2:2) or asymmetric (2:2:1) ternary p75NTR·NGF·TrkA complexes.
Received for publication, March 23, 2005 , and in revised form, July 8, 2005.
* This work was supported in part by Wellcome Trust grants, a Cambridge University Parke-Davis Visiting Fellow Award, and by the Walters-Kundert trust and Biotechnology and Biological Sciences Research Council (to B. T. R., C. V. R., and E. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains Supplemental Data.
1 To whom correspondence should be addressed: Dept. of Biochemistry, University of Cambridge, 80 Tennis Ct. Rd., Cambridge CB2 1GA, UK. Tel.: 44-0-1223-766028; Fax: 44-0-1223-766002; E-mail: jukka{at}cryst.bioc.cam.ac.uk.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |